Invitation of Raytor Lecture- "Preparation Strategy of Insoluble Drugs"

Time: September 15, 2022 (Thursday) 19：30-20：30 Location: Raytor Instruments Knowledge Store (online) Scan code for registration (company / name / contact information) Course Introduction Professor Han Jun, the famous dean of the Institute of Biological Preparations of Liaocheng University and Taishan scholar, was invited to share the preparation strategies for insoluble drugs for pharmaceutical colleagues in this Raytor Lecture. We hope to bring you a better idea of innovative preparation development. Trainer Introduction Professor Han Jun Professor Han Jun, Dean of Biopharmaceutical Research Institute of Liaocheng University, Distinguished Expert of National Major Talent Program, Doctoral Supervisor of Shandong Normal University and Jinan University, Distinguished Professor (Grade II) of "Taishan Scholar" in Shandong Province, Bachelor of Pharmacy of the Second Military Medical University, Doctor of Pharmacy of the University of Minnesota in the United States, and General Manager of Liaocheng Hi tech Biotechnology Co., Ltd Academic member of the Key Laboratory for Research and eva1uation of Generic Drugs (Jinan) of the State Drug Administration, academic member of the National Key Laboratory for Algae Active Substances (Qingdao), and former chief scientist of the National Key Laboratory for Antibody Drugs and Targeted Therapy (Shanghai). Professor Han led the construction of Shandong Antibody Pharmaceutical Collaborative Innovation Center and Shandong Nanodrug and Drug Release System Engineering Technology Research Center in Liaocheng University, and served as the director of the center. At present, he has presided over and participated in many national, provincial and ministerial projects, including the national "major new drug discovery" science and technology major project, and has project cooperation and academic exchanges with dozens of international and domestic enterprises and research institutions. Professor Han has worked and lived in the United States for more than 20 years. He once worked in Sanofi, Pfizer, Abbott, Novartis, Teva and other international pharmaceutical enterprises. Responsible for and participated in the R&D and marketing of dozens of new drugs and hundreds of generic drugs (America), and served as the founding president and the first chairman of the Board of Directors of the American Chinese Biomedical Association (CABA) in Boston.